Sukhani told CNBC-TV18, "I think investors should wait patiently for this bank correction to be over wherever it ends, another 5% or 3% from here, at that point the heavy weights are still buying opportunities on every dip that is ICICI Bank, Axis Bank and State bank of India. On the charts there are some movements on PSU banks but they are not ready to begin a strong upside momentum move, so focus on the heavy weights."
He further added, "For Ranbaxy the charts are not good, they are bearish and dismal. Any rally in Ranbaxy is a selling opportunity. I don't think this stock is going anywhere in a hurry, its probably moving down. For all other pharma stocks they have been moving in a bull market of their own. Now once the other high beta stocks start playing catch up, I think pharma is likely to go into a consolidation. On every dip in Dr Reddys and Sun Pharma , the stocks become a buying opportunity."
